← All stocks

Protagonist Therapeutics, Inc

PTGX Scheduled selling only

CIK 0001377121 #955 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$18.24M

$0.00 on a plan · $18.24M straight out of an exercise

Sold at will

$0.00

0 of 3 sales

Net

−$18.24M

$0.00 against sales at will

By person

9 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

PATEL DINESH V PH D

President and CEO

—

$18.24M (3) scheduled

−$18.24M

522,968

0.8082%

$75.36M

+1.4%

Gupta Suneel

Chief Development Officer

—

267,433

0.4133%

$38.54M

+44.9%

MOLINA ARTURO MD

Chief Medical Officer

—

84,115

0.1300%

$12.12M

+74.0%

SELICK HAROLD E

Director

—

60,845

0.0940%

$8.77M

+117.3%

Ali Asif

Chief Financial Officer

—

59,003

0.0912%

$8.50M

+64.6%

Giraudo Bryan

Director

—

12,695

0.0196%

$1.83M

−54.7%

Waddill William D.

Director

—

7,825

0.0121%

$1.13M

−34.8%

Williams Lewis T

Director

—

7,825

0.0121%

$1.13M

—

O'Dowd Sarah A

Director

—

7,825

0.0121%

$1.13M

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

PATEL DINESH V PH D

10 Sep 2026

President and CEO

Sold after exercise

7,278

$144.10

$1.05M

PATEL DINESH V PH D

9 Sep 2026

President and CEO

Sold after exercise

63,548

$146.18

$9.29M

PATEL DINESH V PH D

8 Sep 2026

President and CEO

Sold after exercise

54,174

$145.87

$7.90M

Show all 3 transactions →

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 3

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 125,510

History held since 15 Sep 2016